Open AccessEffectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
Author(s) -
A. Gómez-Bastero Fernández,
Juan Francisco Medina Gallardo,
Julio Delgado Romero,
Auxiliadora Romero Falcön,
Cristina Benito Bernáldez,
Javier Gallego Borrego,
Francisco Javier Álvarez Gutiérrez
Publication year - 2022
Publication title -
journal of asthma and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.162
H-Index - 30
ISSN - 1178-6965
DOI - 10.2147/jaa.s358705
Subject(s) - mepolizumab , medicine , benralizumab , omalizumab , asthma , refractory (planetary science) , population , emergency department , adverse effect , pediatrics , immunology , eosinophil , immunoglobulin e , antibody , physics , environmental health , psychiatry , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom